Informations générales (source: ClinicalTrials.gov)
oCular Examination at Cell RESolution With Optical TransmissionTomography (CERES-OTT)
Interventional
N/A
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts (Voir sur ClinicalTrials)
novembre 2024
novembre 2029
18 mai 2025
Understanding the pathogenesis of eye diseases has benefited greatly from recent advances
in ophthalmic imaging. However, current clinical imaging systems, such as optical
coherence tomography (OCT), are limited in terms of resolution, acquisition speed or
access to certain eye functions. Our team has participated in the development of a new
generation of imaging technology known as optical transmission tomography (OTT), which
enables imaging of the anterior parts of the eye with high cellular resolution, a wide
field of view and reduced examination delay.
Etablissements
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CHNO DES QUINZE-VINGTS PARIS | Nabil BROUK | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
For Patients:
- 200 subjects aged 18 to 80 years;
- Male or female;
- with an ocular disease affecting the cornea, ocular surface, lens (cataract) or
glaucoma, or requiring refractive surgery or post-refractive surgery follow-up;
- Are covered by the French Assurance Maladie;
- Have signed an express, free and informed consent form.
For Healthy volunteers:
- 100 subjects aged 18 to 80 years;
- Male or female;
- Healthy subjects with no known pathology directly or indirectly affecting ocular
structures;
- Covered by the French Assurance Maladie.
- Having signed an express, free and informed consent form.
For Patients:
- 200 subjects aged 18 to 80 years;
- Male or female;
- with an ocular disease affecting the cornea, ocular surface, lens (cataract) or
glaucoma, or requiring refractive surgery or post-refractive surgery follow-up;
- Are covered by the French Assurance Maladie;
- Have signed an express, free and informed consent form.
For Healthy volunteers:
- 100 subjects aged 18 to 80 years;
- Male or female;
- Healthy subjects with no known pathology directly or indirectly affecting ocular
structures;
- Covered by the French Assurance Maladie.
- Having signed an express, free and informed consent form.
For all participants:
- Inability to hold a still position on a standard ophthalmic chin rest;
- Conjunctivitis or other contagious contact disease in active phase;
- Having an implanted pacemaker or other electronic medical device;
- Having a predisposition to iridocorneal angle closure;
- Vulnerable persons or persons under legal protection (pregnant or breast-feeding
women; persons under guardianship,